Lenalidomide for the treatment of relapsed multiple myeloma

Lancet Oncol. 2009 Jul;10(7):647-8. doi: 10.1016/s1470-2045(09)70169-x.
No abstract available

Publication types

  • News

MeSH terms

  • Antineoplastic Agents / economics
  • Antineoplastic Agents / therapeutic use*
  • Cost-Benefit Analysis
  • Health Care Rationing* / economics
  • Humans
  • Lenalidomide
  • Multiple Myeloma / drug therapy*
  • Quality-Adjusted Life Years
  • Recurrence
  • Technology Assessment, Biomedical* / economics
  • Thalidomide / analogs & derivatives*
  • Thalidomide / economics
  • Thalidomide / therapeutic use
  • United Kingdom

Substances

  • Antineoplastic Agents
  • Thalidomide
  • Lenalidomide